HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monocyte hyporesponsiveness and Toll-like receptor expression profiles in coronary artery bypass grafting and its clinical implications for postoperative inflammatory response and pneumonia: An observational cohort study.

AbstractBACKGROUND:
Cardiac surgery with cardiopulmonary bypass has a major impact on the congenital immune response, in which Toll-like receptors (TLRs) are the first line of defence. Decreased surface expression of TLRs and impaired monocyte responsiveness to TLR ligands occur following surgery. However, the clinical implications of this altered immune response are not clear.
OBJECTIVES:
To study cardiac surgery induced changes in perioperative TLR expression and monocyte responsiveness, and the association with postoperative inflammatory complications.
DESIGN:
A prospective cohort study.
SETTING:
Single university hospital, enrolment March to December 2007.
PATIENTS:
Eighty-four out of 92 patients who underwent coronary artery bypass grafting (CABG) were followed up until hospital discharge.
MAIN OUTCOME MEASURES:
We assessed in-vivo TLR-2 and TLR-4 expression and ex-vivo monocyte responsiveness to TLR-2 and TLR-4 ligands, measured by Pam3Cys and lipopolysaccharide (LPS)-induced interleukin (IL)-6 and IL-8, and tumour necrosis factor alpha (TNF-α) secretion until 24 h after surgery. Patients were followed to identify adverse inflammatory and infectious outcomes.
RESULTS:
Monocyte TLR expression decreased during CABG but returned to baseline after 24 h [linear mixed effects (LME) over time P < 0.0001]. Monocyte responsiveness changed significantly over time, with marked postoperative hyporesponsiveness (LME P < 0.0001). Decreased monocyte responsiveness to LPS was associated with monocyte TLR-4 expression (LME for IL-6 P = 0.04, IL-8 P = 0.002, TNF-α P = 0.05). Intraoperative decrease of monocyte TLR-2 expression was associated with postoperative systemic inflammatory response syndrome (SIRS) and pneumonia [odds ratio (OR) 2.06, 95% confidence interval (95% CI) 1.14 to 3.72], but the perioperative decrease of monocyte TLR-4 expression was not (OR 1.10, 95% CI 0.80 to 1.52).
CONCLUSION:
CABG surgery induced a decrease in in-vivo monocyte TLR expression and also in ex-vivo monocyte responsiveness, with which monocyte TLR-4 expression and monocyte LPS responsiveness seemed to be associated. Decreased TLR-2 expression was associated with the occurrence of SIRS and pneumonia, suggesting a role in the cause of postoperative inflammatory conditions.
REGISTRATION:
Clinicaltrials.gov identifier: NCT00356746.
AuthorsSuzanne Flier, Arno N Concepcion, Dik Versteeg, Teus H Kappen, Imo E Hoefer, Dylan W de Lange, Gerard Pasterkamp, Wolfgang F Buhre
JournalEuropean journal of anaesthesiology (Eur J Anaesthesiol) Vol. 32 Issue 3 Pg. 177-88 (Mar 2015) ISSN: 1365-2346 [Electronic] England
PMID25405275 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Ligands
  • TLR2 protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
Topics
  • Aged
  • Cardiopulmonary Bypass (adverse effects)
  • Coronary Artery Bypass (adverse effects)
  • Coronary Artery Disease (blood, diagnosis, immunology, surgery)
  • Cytokines (blood)
  • Female
  • Hospitals, University
  • Humans
  • Ligands
  • Logistic Models
  • Male
  • Middle Aged
  • Monocytes (drug effects, immunology, metabolism)
  • Multivariate Analysis
  • Netherlands
  • Odds Ratio
  • Pneumonia (immunology, metabolism)
  • Prospective Studies
  • Risk Factors
  • Systemic Inflammatory Response Syndrome (immunology, metabolism)
  • Time Factors
  • Toll-Like Receptor 2 (agonists, blood, immunology)
  • Toll-Like Receptor 4 (blood, immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: